Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
about
Viral hepatitis and hepatocellular carcinomaHepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformationLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaRisk factors for hepatocellular carcinoma in IndiaActivation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular TransformationExpression of hepatoma-derived growth factor in hepatocarcinogenesisExpression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomasGGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosisFibrosis-dependent mechanisms of hepatocarcinogenesisIncidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cellsRBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt.Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.The war on cancer: a report from the front linesNovel insights into the function and dynamics of extracellular matrix in liver fibrosis.No direct role for Epstein-Barr virus in American hepatocellular carcinoma.Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection.Circulating tumor cells measurements in hepatocellular carcinoma.Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control studyEtiologic and epidemiologic study of hepatocellular carcinoma in West Azarbaijan of Iran (2006-2011).Viral genotypes and associated risk factors of hepatocellular carcinoma in India.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea.Hepatocellular carcinoma: an overview.Associations among Genotype 1b Hepatitis C Virus Core Protein, Protein Kinase R, and Signal Transducer and Activator of Transcription 3.Clinical course of hepatitis B surface antigen positive subjects following screening: A retrospective observational study from April 2008 to January 2013.Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.Hepatitis C virus and malignancy.Replication of hepatitis B in HBsAg-positive siblings.Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer.
P2860
Q21245597-CAB26932-72A2-4AFF-9D26-4578D796552FQ22253188-13DD1382-B256-4667-BCC4-3A7C8197C85AQ24234212-8208C69C-979A-4D90-8F50-2AAC456A1BF6Q24236020-761FA7A4-614F-4AE0-8E33-6F95191FED9FQ26830794-33BB9F5F-7DD4-4B96-91F9-7A92C8A22197Q27485121-8C8D80B8-F038-4CC9-B9A2-C9E1A9D02E96Q28208376-4153A4F7-D22D-48AE-92CF-B631143FA7E7Q28268815-5B1778A7-0F8D-4575-9D28-D357EFB5D0C8Q33638516-BA64B2DC-ECEA-4C9F-BBAA-88408C14A138Q33865082-0E2C8D5C-A498-45E7-937C-2F8F8F5203FEQ33906429-CEF08787-19DE-434C-A226-C5C390252CEBQ34081570-372DE373-043D-408F-AFB8-2DA543391145Q34325518-E0A2275E-3EEA-4DBE-9CEF-421ECA316160Q34747158-CA763F74-9A2B-440C-8752-78404059154BQ34779133-20495647-4BF6-411B-AF2F-305B62CAE80DQ35103643-50F4953C-9428-4BAD-9BE9-6EF64CE376A5Q35622533-3767286B-8E3A-4D84-B85B-D1926AF701D4Q35746886-66D71D47-02A6-4C41-856C-45199D2B3155Q35788005-725E5B6A-EB12-4701-8872-03B7B372D6E3Q36011412-E8B9231A-71DB-4446-AD22-CAFC2874B65BQ36622692-8F8AD78F-8C38-4D65-B31E-D2DF8E69FEADQ36745701-21A6B447-05FD-4199-B8A6-C25E4CFDE712Q36814387-5DD3EC85-6E93-4F9D-B289-87F9BEBD4FF0Q37800793-62E0F34B-B6C4-4D7F-AD0E-952C6CB03C0FQ38158226-BCD8CE93-7E5D-4DD8-91E5-4357FB7C001EQ38876753-9B0374C7-2720-414B-A60E-532BF4401674Q40820239-9C3B588B-A5DF-4B40-B2F6-34A60D27C980Q41193967-9925067D-3DFA-485D-BE16-588679252DEAQ42994028-BC9825C5-BB47-4788-9E6F-8408D5FFC081Q42996334-0540AD0D-436A-4D0A-8010-9DD6CECBD33CQ43032321-29240F32-97AA-4E63-B6F6-30F810E46C3EQ44688321-E84FE06B-C9F2-4E7B-AEEA-BAD0226E4B2BQ44934761-67C4D34E-BA95-4A29-B57A-6ED04FF4C226Q49212675-127129B6-A990-4D04-B62C-79BCD346A535Q51912888-23BB3A5E-13AC-48BC-BA4C-3776FD1C65BBQ52355121-F71D5BEF-36B0-48CE-863D-71DC1F8BCD74Q55211469-7B0917F4-32C6-4F44-BF38-CD71DCA98E88
P2860
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@en
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@nl
type
label
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@en
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@nl
prefLabel
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@en
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
@en
P2093
Colantoni A
De Maria N
Van Thiel DH
P2860
P304
P356
10.1046/J.1365-2893.1998.00116.X
P577
1998-09-01T00:00:00Z